Vinod Sharma Selected Research

Therapeutics

1/2024	Update on the systemic management of noninfectious uveitis in children and adolescents.
5/2023	Utility and timing of the ROX index in the prediction of high flow oxygen therapy failure in acute hypoxemic respiratory failure of infective etiology: a prospective observational study.
4/2023	Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from India.
3/2023	Role of Iron Therapy in Heart Failure: A Consensus Statement from India.
1/2021	Oral metronomic therapy in head and neck cancer.
11/2018	Error-related brain activity in pediatric anxiety disorders remains elevated following individual therapy: a randomized clinical trial.
10/2018	Prospective evaluation of integrated device diagnostics for heart failure management: results of the TRIAGE-HF study.
6/2015	Traumatic central serous chorioretinopathy.
1/2015	Role of Tacrolimus only therapy in modified Ponticelli regimen resistant idiopathic membranous glomerulonephritis.
1/2012	Association between serum neopterin and inflammatory activation in chronic kidney disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vinod Sharma Research Topics

Disease

5	Neoplasms (Cancer) 02/2024 - 04/2015
5	Heart Failure 04/2023 - 01/2018
3	Wounds and Injuries (Trauma) 06/2017 - 01/2010
2	Inflammation (Inflammations) 02/2024 - 01/2012
2	COVID-19 05/2023 - 05/2022
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 05/2015
2	Hemorrhagic Fever with Renal Syndrome (HFRS) 10/2018 - 01/2018
1	Vomiting 05/2024
1	Nausea 05/2024
1	Hand-Foot Syndrome 02/2024
1	Necrosis 01/2024
1	Infections 01/2024
1	Uveitis 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Edema (Dropsy) 01/2024
1	Thyrotoxicosis 12/2023
1	Hyperthyroidism 12/2023
1	Graves Disease (Basedow Disease) 12/2023
1	Glaucoma 07/2023
1	Ganglion Cysts (Ganglion) 07/2023
1	Respiratory Insufficiency (Respiratory Failure) 05/2023
1	Sleepiness 03/2023
1	Endocarditis 01/2023
1	Neutropenia 05/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Hypersensitivity (Allergy) 11/2021
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Choroidal Neovascularization 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2020
1	Endophthalmitis (Ophthalmia) 06/2020
1	Breast Neoplasms (Breast Cancer) 05/2020
1	Albinism 01/2020
1	Cataract (Cataracts) 01/2020
1	Ectopia Lentis 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder) 01/2020
1	Carcinoma (Carcinomatosis) 10/2019
1	Penetrating Head Injuries (Penetrating Head Injury) 04/2019
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 04/2019
1	Priapism 01/2019

Drug/Important Bio-Agent (IBA)

2	Indicators and Reagents (Reagents)IBA 09/2023 - 10/2020
2	Retinaldehyde (Retinal)IBA 07/2023 - 01/2020
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 04/2023 - 02/2023
2	Neprilysin (Neutral Endopeptidase)IBA 04/2023 - 02/2023
2	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2019
2	Methylphenidate (Ritalin)FDA LinkGeneric 01/2020 - 05/2015
1	Olanzapine (Zyprexa)FDA Link 05/2024
1	Capecitabine (Xeloda)FDA Link 02/2024
1	Celecoxib (Celebrex)FDA Link 02/2024
1	Diclofenac (SR 38)FDA LinkGeneric 02/2024
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2024
1	cilnidipineIBA 01/2024
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2024
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2024
1	Adalimumab (Humira)FDA Link 01/2024
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2023
1	Methimazole (Thiamazole)FDA LinkGeneric 12/2023
1	Thyroid HormonesIBA 12/2023
1	Propranolol (Inderal)FDA LinkGeneric 12/2023
1	Thyroid-Stimulating ImmunoglobulinsIBA 12/2023
1	Oxygen (Dioxygen)IBA 05/2023
1	Mineralocorticoid Receptor AntagonistsIBA 04/2023
1	Glucose (Dextrose)FDA LinkGeneric 04/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2023
1	sacubitril and valsartan sodium hydrate drug combinationIBA 04/2023
1	SymportersIBA 04/2023
1	SodiumIBA 04/2023
1	AntiemeticsIBA 03/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2023
1	IronIBA 03/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Ado-Trastuzumab EmtansineIBA 05/2020
1	ErbB Receptors (EGF Receptor)IBA 05/2020
1	encorafenibIBA 01/2020
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020
1	binimetinibIBA 01/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	CotinineIBA 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020
1	erdafitinibIBA 10/2019
1	PlatinumIBA 04/2019
1	MetalsIBA 04/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019

Therapy/Procedure

11	Therapeutics 01/2024 - 11/2003
5	Drug Therapy (Chemotherapy) 05/2024 - 01/2018
2	Radiotherapy 01/2021 - 04/2019
1	Orthoptics (Orthoptic) 01/2024
1	Autologous Transplantation 01/2023
1	Stem Cell Transplantation 01/2022
1	Injections 01/2021
1	Noninvasive Ventilation 07/2020
1	Cannula 07/2020
1	Vitrectomy 06/2020
1	Craniotomy 04/2019
1	Highly Active Antiretroviral Therapy (HAART) 01/2019
1	Polypharmacy 01/2019